CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Oak Street Health — Adjusted EBITDA (Non-GAAP) by Year
Oak Street Health — Adjusted EBITDA (Non-GAAP) ($M)
Cvs Health Oak Street Health — Adjusted EBITDA (Non-GAAP): -$286M in FY2022, up 25.1% from a year earlier. No newer figure appears in the documents we track.
Latest, FY2022
-286
Period ended Dec 31, 2022
Change on a year earlier
+25.1%
-229 in FY2021
History
5 years
Since FY2018
Sources
3
Documents cited below
Where the FY2022 figure comes from
“|| Adjusted EBITDA (Non-GAAP) 2 | $ | (286.3) | $ | (228.9) | $ | (92.6)”
Source: OSH 10-K (2023-02-28) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Oak Street Health — Adjusted EBITDA (Non-GAAP) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Dec 31, 2022 | -286 | +25.1% | OSH 10-K (2023-02-28) ↗ |
| FY2021 | Dec 31, 2021 | -229 | +147.2% | OSH 10-K (2023-02-28) ↗ |
| FY2020 | Dec 31, 2020 | -92.6 | +4.9% | OSH 10-K (2023-02-28) ↗ |
| FY2019 | Dec 31, 2019 | -88.3 | +49.7% | OSH 10-K (2022-02-28) ↗ |
| FY2018 | Dec 31, 2018 | -59 | – | OSH 10-K (2021-03-10) ↗ |
Cite this data
StockData. (2026). Cvs Health Oak Street Health — Adjusted EBITDA (Non-GAAP) ($M), annual FY2018–FY2022 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/osh-adj-ebitda
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.